FDA review

FDA launces generative AI tool Elsa a month ahead of schedule

The tool is already being used in clinical protocol reviews, scientific evaluations and to identify high-priority inspection targets, the agency said.

Darren Incorvaia Jun 3, 2025 10:40am

AI artificial intelligence drug development computational biology machine learning

FDA plans to fully adopt generative AI by end of June

May 8, 2025 1:33pm

Make a delay and accumulation of outstanding tasks Full stop

FDA delays force Daré to shelve phase 3 plans: WSJ

Apr 17, 2025 3:03pm

Biotech CEOs say they already feel impact of FDA restructure

Apr 10, 2025 1:56pm

FDA leadership 'decapitated,' former leader Janet Woodcock says

Apr 7, 2025 4:04pm

new ceo hiring fired executive leader chutes

ReCor Medical taps Siemens Healthineers alum as CEO

Jan 3, 2023 12:04pm